US biopharmaceutical finance and the sustainability of the biotech business model

This publication has 44 references indexed in Scilit:

• Finding the Endless Frontier: Lessons from the Life Sciences Innovation System for Technology Policy
  Capitalism and Society, 2010
• The New Economy Business Model and the Crisis of U.S. Capitalism
  Capitalism and Society, 2009
• Predictors of orphan drug approval in the European Union
  European Journal of Clinical Pharmacology, 2008
• The cost of biopharmaceutical R&D: is biotech different?
  Managerial and Decision Economics, 2007
• Estimating The Cost Of New Drug Development: Is It Really $802 Million?
  Health Affairs, 2006
• The price of innovation: new estimates of drug development costs
  Journal of Health Economics, 2003
• Contagious Speculation and a Cure for Cancer: A Nonevent that Made Stock Prices Soar
  The Journal of Finance, 2001
• Are CEOs Really Paid Like Bureaucrats?
  The Quarterly Journal of Economics, 1998
• An Economic Analysis of Biotechnology Patent Protection
  The Yale Law Journal, 1992
• On the Complex Economics of Patent Scope
  Columbia Law Review, 1990